Multiple Myeloma by Thomas MoehlerMultiple Myeloma by Thomas Moehler

Multiple Myeloma

EditorThomas Moehler, Hartmut Goldschmidt

Paperback | May 30, 2013

not yet rated|write a review

Pricing and Purchase Info

$305.32 online 
$336.95 list price save 9%
Earn 1527 plum® points

In stock online

Ships free on orders over $25

Not available in stores

about

Multiple myeloma is currently still an incurable disease, but during the past decade knowledge of its molecular pathogenesis has increased rapidly. This has led to remarkable progress in both diagnosis and therapy, including in particular the approval of novel and first-in-class drugs such as thalidomide, bortezomib, and lenalidomide. This book, written by internationally acknowledged experts, covers a wide range of topics relating to multiple myeloma, including history, epidemiology, pathophysiology, clinical features, staging, and prognostic systems. The principal focus, however, is on therapy, with detailed information on the various promising treatment options which give hope that this cancer will be transformed into a chronic disease or even become curable. Individualized therapy and the variety of supportive treatment options, as described in this volume, will help in achieving this goal, as well as in reducing adverse events and improving quality of life.

Details & Specs

Title:Multiple MyelomaFormat:PaperbackDimensions:364 pages, 9.25 × 6.1 × 0 inPublished:May 30, 2013Publisher:Springer Berlin HeidelbergLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3642267998

ISBN - 13:9783642267994

Look for similar items by category:

Customer Reviews of Multiple Myeloma

Reviews

Extra Content

Table of Contents

History and epidemiology.- Pathophysiology: Molecular biology of plasma cell disorders. Alterations in microenvironment.- Clinical Features: Imaging. Integrated innovative approach for diagnosis and staging.- Therapy: High-dose chemotherapy and ABSCT.- Allogeneic transplantation. Novel Drugs.- Immunotherapeutic approaches.- First-line treatment and maintenance.- Relapse.- Radiotherapy.- Kyphoplasty.- Supportive Therapy.- Appendix: Staging and prognosis systems.